Novavax (NVAX) Return on Equity [ROE] (2011 - 2021)
Novavax's Return on Equity [ROE] came in at -3180.20% for Q4 2021, down 3066.18 percentage points from -114.02% a year earlier and down 3002.05 percentage points from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Return on Equity [ROE] (2011 - 2021) Analysis & Trends
For FY2021, Novavax's Return on Equity [ROE] was -1265.72%, down 1076.11 percentage points from FY2020.
- Return on Equity [ROE] carries a five-year change of -1070.72 percentage points (FY2016 to FY2021).
- Going back by year, Return on Equity [ROE] was -189.60% in FY2020.
- The Q4 2021 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q3 2011.
- Business Quant data shows NVAX's Return on Equity [ROE] at -178.15% (Q3 2021), -106.45% (Q2 2021) and -73.83% (Q1 2021) in the three quarters before Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -3,180.20% |
| Sep 30, 2021 | -178.15% |
| Jun 30, 2021 | -106.45% |
| Mar 31, 2021 | -73.83% |
| Dec 31, 2020 | -114.02% |
| Sep 30, 2020 | -187.33% |
| Jun 30, 2020 | -116.18% |
| Dec 31, 2016 | -1,265.59% |
| Sep 30, 2016 | -377.27% |
| Jun 30, 2016 | -181.65% |
| Mar 31, 2016 | -87.77% |
| Dec 31, 2015 | -47.54% |
| Sep 30, 2015 | -29.04% |
| Jun 30, 2015 | -24.44% |
| Mar 31, 2015 | -29.67% |
| Mar 31, 2014 | -28.30% |
| Dec 31, 2013 | -24.77% |
| Sep 30, 2013 | -32.17% |
| Jun 30, 2013 | -51.61% |
| Mar 31, 2013 | -39.50% |
API Access
Novavax Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();